Epidemiology and assessment of Hepatitis B positive children in Western Australia

Hannah Elizabeth Bartley1,2, Emma Kate Lefroy Turner3, Timothy John Ford4,5

  • 1Departments of General Paediatrics and Refugee Health Service, Perth Children's Hospital, Perth, Western Australia, Australia.

Insights

Chronic hepatitis B (CHB) affects diverse pediatric populations, with high loss to follow-up and suboptimal transfer to adult care. Improved systems are needed to address barriers and ensure long-term health for children with CHB.

Area of Science:

  • Pediatric Hepatology
  • Infectious Diseases
  • Public Health

Background:

  • Chronic hepatitis B (CHB) represents a significant global health challenge, particularly in pediatric populations.
  • Understanding the demographic and clinical characteristics of CHB patients in specialized healthcare settings is crucial for effective management.
  • Tertiary pediatric hospitals serve a unique cohort, often with complex needs and diverse backgrounds.

Purpose of the Study:

  • To characterize pediatric patients with CHB presenting to a tertiary hospital in Western Australia.
  • To evaluate the implementation of previous follow-up recommendations for this cohort.
  • To identify challenges in managing CHB in a diverse pediatric population.

Main Methods:

  • Retrospective analysis of pediatric patients (0-17 years) with HBsAg positivity from 2013-2020.
  • Data collection included demographics, clinical course, and follow-up status.
  • Assessment of transfer rates to adult services and adherence to recommendations.

Main Results:

  • Seventy-four CHB patients identified; mean age 11 years, 55% male.
  • High cultural and linguistic diversity (74% refugee-like backgrounds), with many lacking English proficiency.
  • Significant follow-up issues: 38% missed appointments, 32% lost to follow-up, and suboptimal transfer (56% attended adult care).

Conclusions:

  • CHB burden is higher in culturally diverse groups, necessitating tailored approaches.
  • Significant loss to follow-up and suboptimal transition to adult care require urgent attention.
  • Enhanced recall, education, and referral systems are vital to overcome barriers and ensure lifelong monitoring for CHB patients.
Abstract

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...